日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis.

通过转录组学和蛋白质组学分析表征 FLCN 在 Birt-Hogg-Dubé 综合征细胞模型中的抑癌活性

Jones Rachel-Ann, Dunlop Elaine A, Champion Jesse D, Doubleday Peter F, Claessens Tijs, Jalali Zahra, Seifan Sara, Perry Iain A, Giles Peter, Harrison Oliver, Coull Barry J, Houweling Arjan C, Pause Arnim, Ballif Bryan A, Tee Andrew R

Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells.

靶向 NRF2 和 FSP1 以克服 TSC2 缺陷细胞和癌细胞的铁死亡抵抗性

Tahsin Tasmia, McPhail Darius K, Champion Jesse D, Alzahrani Mohammad A M, Hilditch Madeleine L, Faris-Orr Alexandre, Calver Brian L, Cronin James G, Mareque-Rivas Juan C, Sexton Darren W, Hughes Stephen Fôn, Conlan Robert Steven, Davies David Mark, Tee Andrew R

Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells

药物抑制氧化还原因子-1可恢复结节性硬化症复合物2缺陷细胞中缺氧驱动的变化

Champion, Jesse D; Dodd, Kayleigh M; Lam, Hilaire C; Alzahrani, Mohammad A M; Seifan, Sara; Rad, Ellie; Scourfield, David Oliver; Fishel, Melissa L; Calver, Brian L; Ager, Ann; Henske, Elizabeth P; Davies, David Mark; Kelley, Mark R; Tee, Andrew R